Cargando…
Multidrug resistance-associated protein 4 is a determinant of arsenite resistance
Although arsenic trioxide (arsenite, As(III)) has shown a remarkable efficacy in the treatment of acute promyelocytic leukemia patients, multidrug resistance is still a major concern for its clinical use. Multidrug resistance-associated protein 4 (MRP4), which belongs to the ATP-binding cassette (AB...
Autores principales: | Yuan, Bo, Yoshino, Yuta, Fukushima, Hisayo, Markova, Svetlana, Takagi, Norio, Toyoda, Hiroo, Kroetz, Deanna L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918809/ https://www.ncbi.nlm.nih.gov/pubmed/26497925 http://dx.doi.org/10.3892/or.2015.4343 |
Ejemplares similares
-
Antitumor activity of arsenite in combination with tetrandrine against human breast cancer cell line MDA-MB-231 in vitro and in vivo
por: Yuan, Bo, et al.
Publicado: (2018) -
Arsenite-loaded nanoparticles inhibit PARP-1 to overcome multidrug resistance in hepatocellular carcinoma cells
por: Liu, Hanyu, et al.
Publicado: (2016) -
Cytotoxic Effects of Arsenite in Combination With Gamabufotalin Against Human Glioblastoma Cell Lines
por: Yuan, Bo, et al.
Publicado: (2021) -
Corrigendum: Cytotoxic Effects of Arsenite in Combination With Gamabufotalin Against Human Glioblastoma Cell Lines
por: Yuan, Bo, et al.
Publicado: (2021) -
Criblamydia sequanensis Harbors a Megaplasmid Encoding Arsenite Resistance
por: Bertelli, Claire, et al.
Publicado: (2014)